Yuki Gosei Kogyo Co., Ltd.

Tokyo Stock Exchange 4531.T

Yuki Gosei Kogyo Co., Ltd. Receivables for the year ending March 31, 2024: USD 28.92 M

Yuki Gosei Kogyo Co., Ltd. Receivables is USD 28.92 M for the year ending March 31, 2024, a 28.11% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Yuki Gosei Kogyo Co., Ltd. Receivables for the year ending March 31, 2023 was USD 22.57 M, a -0.55% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Receivables for the year ending March 31, 2022 was USD 22.70 M, a -14.73% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Receivables for the year ending March 31, 2021 was USD 26.62 M, a 29.07% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Receivables for the year ending March 31, 2020 was USD 20.63 M, a -28.62% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
SV Wall Street
Tokyo Stock Exchange: 4531.T

Yuki Gosei Kogyo Co., Ltd.

CEO Seiichiro Matsumoto
IPO Date Jan. 4, 2001
Location Japan
Headquarters 10-4, Nihonbashi-Ningyocho 3-chome
Employees 290
Sector Materials
Industries
Chemicals & Advanced Materials Composite Materials Cosmetics Fertilizers Personal Care Petrochemicals Pharmaceuticals Plastics
Description

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.

StockViz Staff

February 2, 2025

Any question? Send us an email